Sanofi offers Rs 10,000 crores bond linked to access medicine
The company said the costs of financing would be linked to achieving concrete targets in terms of a cumulative number of patients being provided with essential medicines over the next five years.
New Delhi: French healthcare group Sanofi said it had priced a first sustainability-linked bond issue that will be indexed on access to medicines, and worth 1.5 billion euros ($1.7 billion).
The company said the costs of financing would be linked to achieving concrete targets in terms of a cumulative number of patients being provided with essential medicines over the next five years.
The notes are set to be issued in two tranches of 850 million euros and 650 million euros respectively.
"We continue to make progress in our environmental, social and governance activities that are an essential part of our strategy and embedded into our business," said Sanofi chief financial officer Jean-Baptiste de Chatillon.
Read Also - Sanofi, IGM Biosciences collaborate for oncology, immunology, inflammation targets
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. The Sanofi team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. Sanofi provides potentially life-changing treatment options and life-saving vaccine protection to millions of people globally while putting sustainability and social responsibility at the center of our ambitions.
